Product
Immunocytokine NHS-IL12
1 clinical trial
4 indications
Indication
Breast Cancer, Stage IVIndication
Breast CancerIndication
Breast AdenocarcinomaIndication
Stage IV Breast Cancer AJCC v8Clinical trial
REINA: A Phase I Study of Radiation Enhanced IL 12-Necrosis Attraction in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer PatientsStatus: Withdrawn, Estimated PCD: 2022-02-16